Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Active surveillance of low- and mid-risk prostate cancer is becoming a widely accepted alternative to quickly administering more aggressive forms of therapy upon diagnosis. Educating patients on the…
Epstein-Barr virus (EBV), similar to other common viruses, remains in the body indefinitely after exposure and requires constant monitoring by the immune system in order to effectively to…
Precision medicine aims to tailor medical treatments to each patient’s individual genetic profile and biology. Cancer researchers know that patients with particular mutations may respond better to certain…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
There have been many advancements in chemotherapy and immunotherapy treatments for various cancers over the past decade, but the 5-year relative survival rate for glioblastoma patients is still…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
March is Colorectal Cancer Awareness Month. In this installment of 60-Second Symposia, Dr. Lynn O’Connor briefly outlines some statistics and information about colon and rectum cancer that you…
